Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer

スポンサーリンク

概要

• 論文の詳細を見る
• 2008-04-01

著者

• MIKI Yoshio

  Department of Genetic Diagnosis, the Cancer Institute Hospital of JFCR

• Miki Yoshio

  Department Of Clinical Genetic Oncology Cancer Institute Hospital Japanese Foundation For Cancer Res

• Miki Yoshio

  Department Of Molecular Genetics Medical Research Institute Tokyo Medical And Dental University

• NAGASAKI Koichi

  Genome Center, Cancer Institute (Japanese Foundation for Cancer Research)

• Nagasaki Koichi

  Genome Center Cancer Institute (japanese Foundation For Cancer Research)

関連論文

• ゲノム情報を生かした個別化医療 (特集 固形癌の最新治療--癌治療への新たな取り組み) -- (治療の新たな取り組み 個別化治療)
• Recurrence Pattern and Rapid Intraoperative Detection of Carcinoembryonic Antigen (CEA) mRNA in Pleural Lavage in Patients with Non-Small Cell Lung Cancer (NSCLC)
• SF-107-4 大腸sm癌のリンパ節転移と遺伝子群のマイクロアレイによる解析(第107回日本外科学会定期学術集会)
• SY-1-2-5 肝細胞癌の進展機構解析による新規分子標的の同定(シンポジウム1-2 消化器癌の発生機序から見た治療戦略-肝胆膵癌,第62回日本消化器外科学会定期学術総会)
• 発がん・増殖 BRCA遺伝子機能とその機能欠損による乳癌発生機序 (乳癌--基礎と臨床の架け橋)
• 図説 最新のゲノムワイド解析技術 (特集 ゲノム研究最前線--疾患ゲノム研究の現状と展望)
• IS-3-4 乳がん術前化学療法の効果予測システム開発の試み(第108回日本外科会定期学術集会)
• A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
• SF-108-2 大腸癌先進部脱分化に関与する遺伝子群の同定と機能ネットワークの構築(第107回日本外科学会定期学術集会)
• DP-009-4 包括的遺伝子発現解析による膵癌リンパ節転移予測マーカーの同定(第108回日本外科学会定期学術集会)
• Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
• P-7 原発性肺癌切除時の開胸時胸腔内洗浄液におけるCEA-mRNAの検出の意義(一般演題(ポスター) トランスレーショナルリサーチ,第48回日本肺癌学会総会)
• 乳がんのLarge-scale genomic study
• Histological Features of Breast Cancer, Highly Sensitive to Chemotherapy
• Identifying haplotype block structure using an ancestor-derived model
• Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
• Clinicopathological Features of Hereditary Breast Cancer
• Identification of Rad51 alteration in patients with bilateral breast cancer
• High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
• Infrequent Mutation of the H-Cadherin Gene on Chromosome 16q24 in Human Breast Cancers
• Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
• Bilateral Nonpalpable Breast Carcinomas in a Patient with BRCA2 Germ Line Mutation and Past History of Osteosarcoma
• 癌抑制遺伝子BRCA1/2の機能およびPARP阻害剤によるBRCA変異陽性乳癌の治療 (特集 癌治療・発癌・老化の鍵を握るDNA修復経路)
• Familial breast and ovarian cancers
• Analysis of extracellular matrix of a skin tumor from patients with juvenile hyaline fibromatosis
• Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer
• Novel BRCA2-interacting protein BJ-HCC-20A inhibits the induction of apoptosis in response to DNA damage
• The cell death machinery governed by the p53 tumor suppressor in response to DNA damage
• 遺伝子診断の展望 (乳癌--基礎・臨床研究のアップデート) -- (臨床研究 診断 遺伝子診断)
• Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer
• Mutation Analysis of the mel-18 Gene that Shows Decreased Expression in Human Breast Cancer Cell Lines
• Gene Expression Profiling of Breast Cancer
• Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling
• Retrotransposal integration of mobile genetic elements in human diseases
• Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
• Gene expression-based diagnosis of efficacy of chemotherapy for breast cancer
• BRCA2 interacts with the cytoskeletal linker protein plectin to form a complex controlling centrosome localization
• 遺伝性乳癌・卵巣癌の遺伝子診断および研究の現状 (特集 婦人科における遺伝性腫瘍の取扱いの実際)
• Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer
• Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer
• Abnormal collagen deposition in fibromas from patient with juvenile hyaline fibromatosis

もっと見る 閉じる

スポンサーリンク